Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Serine biosynthesis as a novel therapeutic target for dilated cardiomyopathy.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Serine biosynthesis as a novel therapeutic target for dilated cardiomyopathy.
Serine biosynthesis as a novel therapeutic target for dilated cardiomyopathy. Eur Heart J. 2022 09 21; 43(36):3477-3489.
View in:
PubMed
subject areas
Activating Transcription Factor 4
Adenosine Triphosphate
Anti-Inflammatory Agents, Non-Steroidal
Carbazoles
Cardiomyopathy, Dilated
Drug Evaluation, Preclinical
Glucose
Glycine
Humans
Imidazoles
Induced Pluripotent Stem Cells
Molecular Targeted Therapy
Mutation
Myocytes, Cardiac
Phosphoglycerate Dehydrogenase
Protein Kinase Inhibitors
Pyridines
Serine
Troponin T
authors with profiles
Nike Bharucha